the Difference of Follow-up Methods of Neonatal Jaundice

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-10

Study Completion Date

2025-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to compare the effectiveness and efficiency for precaution of severe hyperbilirubinemia in neonate by different follow-up methods of neonatal jaundice. There are two kinds of follow-up methods in the investigators clinical practice. The one is internet plus follow-up model, the other is conventional clinic follow-up method. Parents of the participant neonates can choose one by themselves. After parents of the participant signed informed consent, the investigators recorded several information including severe hyperbilirubinemia, length of phototherapy, follow-up times, et al. Then the investigators analysed these data in order to know what kind of follow-up method is better to prevent severe hyperbilirubinemia and more easy to be accepted.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications

NCT05365984

Hyperbilirubinemia, Neonatal

UNKNOWN NA

The Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants

NCT01762189

Hyperbilirubinemia, Neonatal

COMPLETED

Associations of Nighttime Light Exposure During Pregnancy With Neonatal Jaundice：a Multi-centre Prospective Study in China

NCT03805165

Jaundice, Neonatal

COMPLETED

Multi-center Clinical Study on Neonatal Hyperbilirubinemia

NCT03824990

Quality Improvement Hyperbilirubinemia, Neonatal

COMPLETED NA

TCB Self-Monitoring in Healthy Term and Near-Term Neonates

NCT06645158

Hyperbilirubinemia, Neonatal

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Jaundice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observation group

Intelligent jaundice instrument and Internet plus system for home monitoring and remote follow-up

internet plus model

Intervention Type BEHAVIORAL

Intelligent transcutaneous bilirubin meter and Internet plus model for neonatal jaundice monitoring at home and remote follow-up

control group

follow-up by conventional methods ； hospital or community follow-up depending on arrangement

control

Intervention Type BEHAVIORAL

follow-up by conventional methods; hospital or community follow-up depending on arrangement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

internet plus model

Intelligent transcutaneous bilirubin meter and Internet plus model for neonatal jaundice monitoring at home and remote follow-up

Intervention Type BEHAVIORAL

control

follow-up by conventional methods; hospital or community follow-up depending on arrangement

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Gestational age ≥ 28 weeks, corrected gestational age ≤ 44 weeks;
2. Presence of skin yellowing, percutaneous measurement of jaundice or serum bilirubin concentration less than the phototherapy warning value for the same gestational age and day age group;
3. The vital signs are stable and meet the discharge requirements;
4. Agree to participate in this project and sign an informed consent form;
5. Parents have a certain understanding ability to cooperate in this study;

Exclusion Criteria

1. Direct bilirubin ≥34mmol/L;
2. Increased hepatic enzyme level more than twice of normal value;
3. Those infants who have developed bilirubin encephalopathy or neurological damage due to other reasons before follow-up;
4. Unable to continue follow-up due to other diseases.

Minimum Eligible Age

0 Days

Maximum Eligible Age

16 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No